Mareike Roth

2.4k total citations
16 papers, 909 citations indexed

About

Mareike Roth is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mareike Roth has authored 16 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mareike Roth's work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). Mareike Roth is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). Mareike Roth collaborates with scholars based in Austria, United States and Germany. Mareike Roth's co-authors include Johannes Zuber, Inês Amorim Monteiro Barbosa, Matthias Muhar, Thomas Hoffmann, Barbara Hopfgartner, Christof Fellmann, Barbara Werner, Meinrad Busslinger, Markus Jaritz and Elin Axelsson and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The EMBO Journal.

In The Last Decade

Mareike Roth

16 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mareike Roth Austria 10 637 190 160 149 146 16 909
Sietske T. Bakker United States 11 822 1.3× 305 1.6× 143 0.9× 126 0.8× 221 1.5× 13 1.2k
Anna Kilbey United Kingdom 17 647 1.0× 249 1.3× 82 0.5× 217 1.5× 163 1.1× 35 891
Todd Ashworth United States 12 622 1.0× 175 0.9× 60 0.4× 134 0.9× 131 0.9× 13 851
Masamitsu Negishi Japan 15 1.1k 1.7× 305 1.6× 252 1.6× 186 1.2× 150 1.0× 16 1.3k
Beatriz Aranda-Orgillés United States 13 1.1k 1.8× 235 1.2× 147 0.9× 260 1.7× 142 1.0× 17 1.3k
Yizhou Huang China 14 637 1.0× 89 0.5× 225 1.4× 117 0.8× 127 0.9× 35 880
Kwok Peng Ng United States 14 552 0.9× 174 0.9× 79 0.5× 112 0.8× 106 0.7× 20 741
Simon Raffel Germany 12 510 0.8× 414 2.2× 147 0.9× 145 1.0× 310 2.1× 27 920
Tetsuharu Shinjyo Japan 10 453 0.7× 131 0.7× 88 0.6× 181 1.2× 157 1.1× 13 703
Christopher A. Bristow United States 15 586 0.9× 215 1.1× 224 1.4× 243 1.6× 93 0.6× 30 995

Countries citing papers authored by Mareike Roth

Since Specialization
Citations

This map shows the geographic impact of Mareike Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mareike Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mareike Roth more than expected).

Fields of papers citing papers by Mareike Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mareike Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mareike Roth. The network helps show where Mareike Roth may publish in the future.

Co-authorship network of co-authors of Mareike Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Mareike Roth. A scholar is included among the top collaborators of Mareike Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mareike Roth. Mareike Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Carlet, Michela, Karin Schmelz, Tobias Herold, et al.. (2022). X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. EMBO Molecular Medicine. 15(1). e14557–e14557. 5 indexed citations
2.
Weber, Susanna, Philippe N. Tobler, Lori Asarian, et al.. (2022). Is It Worth It? Obesity Affects Snack Food Valuation Across the Menstrual Cycle. Frontiers in Neuroscience. 16. 800976–800976. 2 indexed citations
3.
Roth, Mareike, et al.. (2022). Designing Emotion. 1 indexed citations
4.
Fuchs, Marina, Sara Weirich, Mareike Roth, et al.. (2021). A functional LSD1 coregulator screen reveals a novel transcriptional regulatory cascade connecting R-loop homeostasis with epigenetic regulation. Nucleic Acids Research. 49(8). 4350–4370. 17 indexed citations
5.
Skucha, Anna, Mareike Roth, Thomas Eder, et al.. (2018). MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nature Communications. 9(1). 1983–1983. 43 indexed citations
6.
Smeenk, Leonie, Maria Fischer, Sabine Jurado, et al.. (2017). Molecular role of the PAX 5‐ ETV 6 oncoprotein in promoting B‐cell acute lymphoblastic leukemia. The EMBO Journal. 36(6). 718–735. 31 indexed citations
7.
Delás, M. Joaquina, Leah R. Sabin, Egor Dolzhenko, et al.. (2017). lncRNA requirements for mouse acute myeloid leukemia and normal differentiation. eLife. 6. 60 indexed citations
8.
Carlet, Michela, et al.. (2016). X-Linked inhibitor of apoptosis protein (XIAP) exhibits an essential role of patients' acute lymphoblastic leukemia cells growing in vivo. European Journal of Cancer. 69. S58–S59. 1 indexed citations
9.
Nowacka‐Woszuk, Joanna, et al.. (2016). MEK1 is required for the development of NRAS-driven leukemia. Oncotarget. 7(49). 80113–80130. 5 indexed citations
10.
Rudolph, Dorothea, Claudia Blaukopf, Christoph Sommer, et al.. (2015). Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia. Journal of Pharmacology and Experimental Therapeutics. 352(3). 579–589. 50 indexed citations
11.
Matthews, Geoffrey M., Parinaz Mehdipour, Leonie A. Cluse, et al.. (2015). Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies. Blood. 126(21). 2392–2403. 46 indexed citations
12.
Schwickert, Tanja A., Hiromi Tagoh, Sinan Gültekin, et al.. (2014). Stage-specific control of early B cell development by the transcription factor Ikaros. Nature Immunology. 15(3). 283–293. 158 indexed citations
13.
Matthews, Geoffrey M., Leonie A. Cluse, Eric Wang, et al.. (2014). Abstract 5533: RNAi-mediated depletion of histone deacetylases highlights the potential for isoform-specific inhibitors in B-cell lymphoma and acute myeloid leukemia. Cancer Research. 74(19_Supplement). 5533–5533. 1 indexed citations
14.
Demajo, Santiago, Iris Uribesalgo, Arantxa Gutiérrez, et al.. (2013). ZRF1 controls the retinoic acid pathway and regulates leukemogenic potential in acute myeloid leukemia. Oncogene. 33(48). 5501–5510. 19 indexed citations
15.
Fellmann, Christof, Thomas Hoffmann, Barbara Hopfgartner, et al.. (2013). An Optimized microRNA Backbone for Effective Single-Copy RNAi. Cell Reports. 5(6). 1704–1713. 443 indexed citations
16.
Krishnan, Keerthana, C. W. Ross, Paul T. Adams, Amélia Pereira, & Mareike Roth. (1994). Neural cell-adhesion molecule (CD 56)-positive, t(8; 21) acute myeloid leukemia (AML, M-2) and granulocytic sarcoma. Annals of Hematology. 69(6). 321–323. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026